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Background: Automaticity of cardiac devices is designed to reduce the burden on
physicians while securing patient safety. The aim of this study is to elucidate accuracy of
automatic adjustment algorithm of pacing output and eﬀectiveness of this feature for time
reduction during clinic visits.
Methods and Results: Patients implanted with pacemakers capable of automatically
adjusting the pacing output were enrolled. During their routine device follow-ups, pacing
thresholds were compared between manual measurements and most recently recorded data
in the device, which had been measured automatically at prespeciﬁed timing. Diﬀerence
between 0:25 and 0.5 volts were predeﬁned as equivalent. Time required for conventional
follow-up was also compared to device interrogation and data assessment. A total of 359
patients from 32 centers were enrolled. Calculated 95% conﬁdence interval of diﬀerence in
volts for atrium was ð0:0625; 0Þ and the diﬀerence for ventricle was nonsigniﬁcant. These
results met the equivalence criteria. Observed time to interrogate and assess device-stored
pacing threshold was shorter by average of 3.3 minutes compared to manual method.
Conclusions: The pacing threshold determined by the automatic measurement algorithm
was accurate. Follow-up time was shorter when utilizing automaticity of pacemakers. The
system is safe and time eﬃcient.
(J Arrhythmia 2011; 27: 307–313)
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Introduction
The number of patients treated for their cardio-
vascular diseases with implantable devices such as
pacemakers has been growing over the years.
Current devices have the capability of continuous
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cardiac monitoring and storage for long-term trends
of cardiac rhythms, episodes and physical condi-
tions. These data are often interrogated and assessed
during in-oﬃce visits with the use of appropriate
programmers. Ever-growing demand for implantable
device follow-ups is pushing the clinics’ capability
to their limits. Reduction of burden by any means
would greatly impact the quality of care given by
these physicians.
Automaticity in cardiac devices has a potential
to address this issue. Automatic conﬁguration of
devices started in 1960s with the introduction of
inhibitory ventricular pacing mode.1) Recent ad-
vancement in software technology is allowing
various electrical parameters to be monitored con-
tinuously and reconﬁgure the device accordingly.2,3)
Improvement with patient safety could be achieved
through periodic pacing threshold monitoring and
reprogramming of pacing pulse parameters with
physician-deﬁned safety margin by utilizing an
algorithm, which automatically adjusts pacing out-
put. This feature is known as automatic capture
management. Reﬁnement of pacing output may also
increase device longevity by conserving battery
energy.4,5) Automatic capture management has the
potential to reduce the burden on physicians and
healthcare economics by minimizing the number of
patient visits, since threshold testing is one of the
major purposes of frequent clinic visits. The time-
saving eﬀectiveness of these features has not yet
been fully elucidated in the Japanese medical
environment. In this report, accuracy of automatic
threshold testing is compared against manual method
along with diﬀerence in time spent for device
checkups.
Methods
This was a prospective, multicenter, observational
clinical study conducted at 32 centers in Japan. It
was approved by the Institutional Review Board or
Medical Ethics Committee at each study center, and
was carried out in accordance to Ethical Guidelines
for Clinical Studies (Ministry of Health, Labour and
Welfare, July 30, 2003, amended on December 28,
2004). Patients with existing and newly implantated
pacemakers were both eligible for enrollment. Sub-
jects must be implanted with permanent cardiac
pacemakers equipped with an automatic capture
management system (Adapta or Sensia series pace-
makers, Medtronic, Inc., Minneapolis, MN, USA),
and willing to sign the informed consent. Patients
with diﬃculty making scheduled follow-up visits or
medical conditions not allowing the use of automatic
capture management were excluded. Since automatic
capture management does not function in AAI(R)
mode, patients with a device programmed with this
parameter were also excluded.
Safety and eﬃcacy objectives were predeﬁned.
For safety, accuracy of pacing threshold values
recorded by automatic capture management was
evaluated in atrium (atrial capture management:
ACM) and ventricle (ventricular capture manage-
ment: VCM). ACM/VCM were programmed with
either monitor only mode or adaptive mode, which
automatically reprogram pacing output with physi-
cian determined safety margin after the automatic
threshold measurements. These measurements are
made daily at a time speciﬁed by the physician.
During the scheduled follow-up visits, subjects ﬁrst
received conventional device checkups. The device
was interrogated, followed by manual pacing thresh-
old testing at pulse width of 0.4ms. P- and R-wave
amplitudes were also measured. After completion,
the device was interrogated once again to conﬁrm
the most recent pacing voltage threshold conﬁgured
by ACM and VCM features. The device was
reprogrammed, if necessary. The automatic capture
management was deﬁned safe when the diﬀerence
between the most recent ACM/VCM conﬁgured
voltage threshold and conventional measurements
are within the range of 0:25 and 0.5 volts. Since
voltage threshold could only be conﬁgured in 0.25V
increments in these devices, aforementioned criteria
is equivalent to maintaining the diﬀerence within a
single notch for safety and two notches from a
battery consumption standpoint.
Details of ventricular6) and atrial7) capture man-
agement are described elsewhere. Brieﬂy, VCM
algorithm utilizes evoked response to pacing output
in the ventricle to conﬁrm capture of myocardium.
Since evoked response in the atrium is prone to false
detection due to its small electrical reaction, ACM
uses two diﬀerent methods to detect atrial capture.
If a patient has stable sinus rhythm, the device
selects atrial chamber reset (ACR) method.8) Atrial
test pacing is delivered slightly faster than intrinsic
sinus rhythm. If the sinus node was reset, it was
determined that the test pace had captured the
atrium. When a patient lacks stable sinus rhythm
but retains intrinsic atrioventricular conduction
(AVC), the device will choose AVC method.9)
Duration between atrial test pace and ventricular
sensing will be monitored. If this duration falls
within a certain time window, the device would
conﬁrm the capture of atrial chamber.
Comparison was made between the time spent on
conventional device follow-up and device evaluation
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utilizing automatic capture management. For both
methods, the time was recorded when initiating
device interrogation with the programmer, and when
‘‘End Session’’ button has been pressed. The time
required to make all conventional measurements and
to conﬁrm ACM/VCM data from interrogated
device report were noted. For physicians who
routinely use auxiliary ECG recorder during device
checkups, the time required to place and remove
ECG electrodes was also measured.
Categorical data were expressed as numbers and
percentile. Age of subjects was shown with mean
and standard deviation. Box plot was used to
demonstrate all other continuous data. Top and
bottom of the box represented ﬁrst and third
quartiles. Thick line showed the median, whereas
whiskers represented maximum and minimum num-
bers. Hodges-Lehmann estimator was calculated in
order to obtain robust estimation. Paired-sample
Wilcoxon signed rank test was used to compare the
diﬀerences between two sets of samples.
Results
Patient Population
The ﬁrst enrollment occurred on February 7, 2008,
and the ﬁnal follow-up was completed on February
2, 2010. Data received before the cutoﬀ date of
March 12, 2010 was analyzed. Data from a total of
359 enrolled subjects were collected from 32 centers
in Japan. The follow-up studies were conducted
within the ﬁrst week of device implantation for 115
(32%) of these subjects. None of the subjects exited
the study prior to their scheduled visits. Patient
demographics are shown in Table 1. Forty-three
percent of the population was male, and mean age
at enrollment was 77:1 11:0 years. Most prom-
inent arrhythmic diagnosis was sick sinus syndrome
and atrioventricular block for 38 and 43 percent of
subjects, respectively. Comorbidity of these condi-
tions was present in 10% of the population. Atrial
tachycardia and/or atrial ﬁbrillation were observed
in 17%. At baseline visit, majority of devices was
programmed with DDD(R) mode (252/359: 70%).
Single-chamber pacing mode was applied to 27% of
subjects.
Pacing Threshold Comparison
Valid datasets from both of ACM and conven-
tional measurements were obtained from 231 sub-
jects. Sixty-ﬁve (28%) of these subjects completed
the follow-up studies within the ﬁrst week after
device implantation. Since the device programming
of VVI(R) and VDD mode is incompatible with
ACM, the data was not collected from 97 patients.
Subjects who were experiencing atrial ﬁbrillation at
time of measurements were also excluded. Manual
measurement in 12 subjects was unsuccessful due to
atrial ﬁbrillation, of which automatic measurement
was successful in 7 subjects. There were cases of
atrial lead dislodgement, leads exhibiting unreliable
sensing, and unstable atrial intracardiac electro-
cardiograms (ECGs). In two of the cases, the ACM
did not function because of high threshold. Statistical
analysis by paired-sample Wilcoxon signed rank test
concluded that 95% conﬁdence interval of median
from observed diﬀerence between ACM and con-
ventional measurements was ð0:0625; 0Þ volts.
This met the criteria of maintaining the diﬀerence
within 0:25 and 0.5 volts.
Three hundred forty-eight valid datasets from
ventricle pacing thresholds were collected. Of these
subjects, 113 (32%) received their devices within a
week. Reasons for exclusion were incompatible lead
systems and unstable intracardiac ECG. Observed
diﬀerence between VCM and conventional measure-
ments were deemed nonsigniﬁcant, thus fulﬁlling the
safety criteria (Table 2).
Distribution of observed pacing threshold is
shown in Figure 1. Median values for all settings
were 0.5 volts with the exception of VCM, which
was 0.625 volts. Measured data were spread in wide
spectrum with deviation toward 0.5 volts. The
diﬀerence between automatic and conventional
measurements falling outside of predeﬁned criteria
occurred in 7/231 (3.0%, range: 0:75, 0.625),
5/348 (1.4%: range: 3, 0.875) patients for ACM
and VCM, respectively. Within these subjects, the
Table 1 Patient demographics
N ¼ 359
Age 77:1 11:0
Gender: Male 154 (43)
Brady arrhythmia
SSS 136 (38)
AVB 154 (43)
SSS þ AVB 35 (10)
Unknown 34 (9)
Atrial Arrhythmia (AT/AF) 61 (17)
Device Mode
VVI(R) 77 (21)
VDD 20 (6)
DDI(R) 10 (3)
DDD(R) 252 (70)
Numbers in parenthesis are percentiles. SSS: sick sinus
syndrome, AVB: atrioventricular block
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failure occurred during the ﬁrst week of implantation
in 6/65 (9.2%) patients with ACM and 2/113 (1.8%)
with VCM.
Time Required for Device Evaluation
Within the total subject population, average time
required to perform conventional pacemaker check-
ups was 5.2 minutes, whereas 2.0 minutes were spent
to conﬁrm ACM and/or VCM data. Median of
observed diﬀerence in time between conventional
and automatic measurements was 2.5 minutes with
95% conﬁdence interval of ð2:5; 3:0Þ. As it may be
obvious, dual chamber conﬁgurations had the ten-
dency to take more time than single chamber settings
(Table 3).
In order to assess the possible inﬂuence of
experience with device checkups, the data was
divided into two groups; measurements made by
healthcare professionals (167/359: 47%) and spon-
sor’s representatives under physicians’ supervision
(192/359: 53%). The average time required to
perform conventional and automatic checkups for
healthcare professionals were 6.9 and 2.8 minutes,
respectively. The sponsor’s representatives per-
formed the same tasks in 3.8 and 1.3 minutes,
respectively. The comparison between the groups
indicated that the sponsor’s representatives spent
signiﬁcantly less time to perform both tasks (p <
0:001). As shown with total subject population,
automatic checkups took signiﬁcantly shorter time
than conventional method for both groups (p <
0:001).
In this study, surface ECG electrodes were placed
on 246 out of 359 subjects (69%) during the device
follow-up. Average time required to apply and
remove the electrodes were 1.5 and 1.3 minutes,
respectively. In Figure 2 a schematic drawing of time
saving with the use of automatic capture manage-
ment for subjects with device reprogramming is
presented. Average time required for ECG electrode
application and removal, conventional device fol-
low-up, and device reprogramming is 2.8, 5.2 and
1.4 minutes, respectively, with a total of 9.4 minutes.
If the automatic capture management features were
fully utilized and auxiliary ECG was not being
observed, the device follow-up time could be
reduced to 3.4 (¼ 2:0þ 1:4) minutes.
Discussion
In this study, safety on the use of ACM and VCM
was evaluated. Time saving eﬀectiveness with the
use of these features was also assessed. A total of
359 patients were enrolled throughout Japan.
The study demonstrated that pacing threshold
measurements of permanent pacemakers made by
automatic capture management were statistically
equivalent to conventional manual method. Manual
measurements in the atria could not be made in
twelve subjects due to atrial tachyarrhythmia during
their clinic visits. Seven of these subjects had
successful automatic measurements. Since the de-
Table 2 Comparison of pacing voltage threshold
(Unit: V)
Hodges-Lehmann Estimator (Mean) 95% CI
of Difference p Value
Automatic Conventional Difference (A-C)
Atrium 0.500 0.500 0.000 ð0:0625; 0Þ <0:01(N ¼ 231) (0.525) (0.551) (0:0260)
Ventricle 0.625 0.625 0.000 ð0; 0Þ 0.263(N ¼ 348) (0.648) (0.663) (0:0144)
CI: Conﬁdence Interval
A B
Figure 1 Comparison of automatic versus manual threshold
measurements.
The box shows ﬁrst and third quartiles of pacing threshold
voltages with median in thicker line. Whiskers represent highest
and lowest values. (A) atrial and (B) ventricular capture manage-
ment. CONV indicates conventional (manual) measurement.
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vices make multiple attempts in case of unsuccessful
threshold measurements, ACM may have additional
beneﬁt for patients with paroxysmal atrial ﬁbrilla-
tion. There were three documented instances of
unstable atrial intracardiac ECG, which caused ACM
to fail. It was speculated that the medication to
control atrial ﬁbrillation may have been the cause of
unstable P-wave.
There were a total of 12 cases which did not fulﬁll
the equivalence criteria for the diﬀerence in thresh-
old measurements. The test was performed within
the ﬁrst week of implantation for eight of these cases
implicating that unstable lead/tissue interaction may
cause false readings. Other causes may include
physical condition of the individuals, medication,
comorbidity, and/or circadian variation. Due to
possible loss of capture for the patient who was
documented with 3V of diﬀerence between auto-
matic and manual measurements, the clinical data
were further evaluated. The device-recorded VCM
threshold indicated that the threshold voltage trended
between 0.875 and 1.125 volts during the period of
one month prior to and 13 months after the study
follow-up date. The manual measurements made
during subsequent clinic visits conﬁrmed that the
readings were within the predeﬁned equivalence
criteria. The current Medtronic pacemakers are
programmed to perform daily threshold measure-
ments, thus making this feature safer for the patients
than periodical clinic visits.
Precautions should be exercised in certain patient
populations. During the acute phase after lead
Table 3 Comparison of device follow-up time
(Unit: min)
Conventional Automatic Difference (C-A)(95% CI) p Value
Total HLe 4.0 1.5 2.5 <0:001
(N ¼ 359) 1Q–3Q 3–5 1–2 ð2:5;3:0Þ
Range 1–48 0–22
Mean 5.2 2.0
Single Chamber HLe 3.5 1.0 2.0 <0:001
(N ¼ 97) 1Q–3Q 2–5 1–2 ð2:0;2:5Þ
Range 1–33 0–15
Mean 4.9 1.8
Dual Chamber HLe 4.5 1.5 3.0 <0:001
(N ¼ 262) 1Q–3Q 3–5 1–2 ð2:5;3:0Þ
Range 1–48 0–22
Mean 5.4 2.0
CI: conﬁdential interval, HLe: Hodges-Lehmann estimator, 1Q–3Q: 1st & 3rd quartiles
Figure 2 Time reduction with automatic
threshold measurement.
When utilizing automatic threshold measure-
ment features of implantable cardiac devices,
there may not be a need to apply ECG electrodes
to the patients. Together with reduction in
device follow-up time, average time of 6.1
minutes may be conserved.
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implantation, especially in the atrium, automatic
threshold tests are prone to false measurements. In
order to ensure patient safety, ‘‘Acute Phase Re-
maining’’ parameter may be utilized. When this
parameter is activated, the device will not lower the
pacing output even if ACM/VCM measured lower
threshold. Patients with frequent premature contrac-
tions should also be closely followed. As for
additional patient safety, the pacing output will only
be decreased by 0.125V when ACM/VCM meas-
ured lower pacing threshold. Physician determined
‘‘Amplitude Safety Margin’’ and ‘‘Minimum Adapt-
ed Amplitude’’ parameters are also eﬀective to avoid
possible loss of capture.
When ACM/VCM is programmed at adaptive
mode, the device adjusts its pacing output according
to the daily threshold measurements. This would
secure patient safety by ensuring capture of myocar-
dium while prolonging device longevity by mini-
mizing battery drainage.4,5,10) During the clinic
visits, device reprogramming was done in 21%
(77/359) of subjects. There were 47 cases with
descriptions of parameter changes, of which 20
subjects had only their pacing output modiﬁed. If the
pacing output was automatically adjusted using
ACM/VCM, these patients could have had shorter
clinic visits, or even had the opportunity to skip the
visit.
As for the general practice in Japan, diagnostic
ECG are recorded in speciﬁc examination environ-
ment, and in most cases ECG during device follow-
ups are only used to verify device functionalities. If
the diagnostic reporting features of cardiac devices
were fully utilized, it may be unnecessary to connect
a patient to an auxiliary ECG recorder. This may
contribute to time reduction during the routine
checkups.
By combining automaticity of pacemakers and
remote monitoring technology for these devices,
reduction in the frequency of clinic visits may be
achievable while maintaining patient safety. The
number of patients implanted with cardiac pace-
makers is growing rapidly worldwide with over-
whelming burden on device clinics and physicians.
Results from studies evaluating the ease of use and
the eﬀectiveness of remote monitoring system on
ICD11) and CRT-D12) patients has demonstrated
positive acceptance of this system. A report from
Lazarus has shown earlier detection of clinical and
device-related events with the use of remote mon-
itoring system by analyzing worldwide database.13)
These results suggest that appropriate implementa-
tion of remote monitoring is a safe and eﬀective
approach to reducing the workload of device
clinicians. Medical economic evaluation when using
the remote monitoring system has also been per-
formed in Europe.14) The inﬂuence of cost eﬀective-
ness could not be applied directly to global regions,
but may aﬀect healthcare expenditure.
The following limitations apply to this study. The
pacing threshold is inﬂuenced by pharmacological
and physiological factors.15,16) In this study, auto-
matic measurements were made prior to clinic visits,
nominally programmed to perform the task when the
subjects are resting, to minimize follow-up time.
Therefore, the result may not represent outcomes
from simultaneous measurements. The time required
to perform threshold measurements highly depends
on personal experience with device checkups. Even
though the individual experience was not evaluated
in this study, a large number of centers were enrolled
in order to reﬂect average procedural time in Japan.
A half of the reported measurements were made by
sponsor’s representatives. This may have acted as a
bias toward the outcome, but they were supervised
by the physicians and statistical analysis revealed
that signiﬁcantly shorter time was required for both
checkup methodologies in this group compared to
that of the healthcare professionals alone.
Conclusions
The current study demonstrated that pacing
threshold measurements made by ACM and VCM
were clinically equivalent to conventional manual
method. By fully utilizing automatic capture man-
agement features, patients may require less routine
clinic visits, thus reducing the ever-expanding work-
load for physicians.
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Appendix
Following is the list of participating investigators and centers.
Shuntaro Ikeda, MD, Division of Cardiology, Uwajima City
Hospital; Hiromi Obata, MD, Department of Cardiology, Obihiro
National Hospital, Takayuki Uchida, MD, Department of Car-
diovascular Surgery, Iizuka Hospital; Yuichi Tsunoda, MD,
Department of Cardiology, Okitama Public General Hospital;
Tetsuro Kohya, MD, Department of Cardiovascular Medicine,
Sapporo Medical Center NTT EC; Yoshihiko Mochizuki, MD,
Department of Cardiovascular Surgery, Ashikaga Red Cross
Hospital; Motonobu Hayano, MD, Department of Cardiology,
Nagasaki Rosai Hospital; Masao Nishimura, MD, Department of
Cardiology, Ageo Central General Hospital; Yoshio Yamanouchi,
MD, Department of Cardiology, Fukuoka University Chikushi
Hospital; Yasuhiro Ishii, MD, Division of Cardiology, Ogikubo
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Hospital; Toshihiro Amaki, MD, Department of Cardiology,
Teikyo University Chiba Medical Center; Masafumi Sueshiro,
MD, Division of Cardiovascular Surgery, Chugoku Rousai
Hospital; Toshihiro Nakamura, MD, Departments of Cardiology,
National Hospital Organization Kyushu Medical Center; Hiroshi
Kanda, MD, Division of Internal Medicine, Hamamatsu Rosai
Hospital; Shin-ichi Ando, MD, Division of Cardiovascular
Medicine, Saiseikai Futsukaichi Hospital; Toshihiko Yamasa,
MD, Department of Cardiology, Sasebo City General Hospital;
Takashi Murakami, MD, Department of Cardiovascular Surgery,
Iwakuni Clinical Center; Kenji Sadamatsu, MD, Department of
Cardiology, Saga Prefectural Hospital KOSEIKAN; Takeshi
Mitsuhashi, MD, Division of Cardiovascular Medicine, Jichi
Medical University Hospital; Hiroo Noguchi, MD, Department of
Cardiology, Fukuoka Wajiro Hospital; Masato Sakamoto, MD,
Department of Cardiovascular Surgery, Kyushu Kosei-Nenkin
Hospital; Tetsuo Yagi, MD, Division of Cardiology, Sendai City
Hospital; Hideki Oka, MD, Division of Cardiology, Health
Insurance Hitoyoshi General Hospital; Keisuke Watanabe, MD,
Division of Cardiology, Tokyo Medical University Hachioji
Medical Center; Naohide Tanaka, MD, Department of Cardiology,
National Hospital Organization Yokohama Medical Center;
Masahiro Ogawa, MD, Department of Cardiology, Fukuoka
University Hospital; Hidehiko Ajisaka, MD, Department of
Cardiology, Asakura Medical Association Hospital; Hiroshi Ogi,
MD, Department of Cardiology, Onomichi General Hospital.
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